MetLife Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768K | Hold |
94,937
| – | – | ﹤0.01% | 1454 |
|
|
2025
Q1 | $796K | Buy |
94,937
+298
| +0.3% | +$2.5K | ﹤0.01% | 1475 |
|
|
2024
Q4 | $750K | Buy |
94,639
+2,297
| +2% | +$18.2K | ﹤0.01% | 1570 |
|
|
2024
Q3 | $768K | Hold |
92,342
| – | – | ﹤0.01% | 1549 |
|
|
2024
Q2 | $586K | Buy |
92,342
+35,634
| +63% | +$226K | ﹤0.01% | 1634 |
|
|
2024
Q1 | $344K | Sell |
56,708
-12,102
| -18% | -$73.3K | ﹤0.01% | 1893 |
|
|
2023
Q4 | $418K | Hold |
68,810
| – | – | ﹤0.01% | 1798 |
|
|
2023
Q3 | $290K | Hold |
68,810
| – | – | ﹤0.01% | 1981 |
|
|
2023
Q2 | $213K | Buy |
68,810
+40,998
| +147% | +$127K | ﹤0.01% | 2233 |
|
|
2023
Q1 | $38.7K | Sell |
27,812
-18,734
| -40% | -$26K | ﹤0.01% | 2732 |
|
|
2022
Q4 | $92.6K | Sell |
46,546
-9,482
| -17% | -$18.9K | ﹤0.01% | 2623 |
|
|
2022
Q3 | $113K | Buy |
56,028
+26,741
| +91% | +$54K | ﹤0.01% | 2624 |
|
|
2022
Q2 | $93.1K | Sell |
29,287
-29,026
| -50% | -$92.3K | ﹤0.01% | 2734 |
|
|
2022
Q1 | $243K | Buy |
58,313
+36,668
| +169% | +$153K | ﹤0.01% | 2237 |
|
|
2021
Q4 | $104K | Sell |
21,645
-18,760
| -46% | -$89.9K | ﹤0.01% | 2395 |
|
|
2021
Q3 | $216K | Hold |
40,405
| – | – | ﹤0.01% | 2044 |
|
|
2021
Q2 | $207K | Hold |
40,405
| – | – | ﹤0.01% | 2155 |
|
|
2021
Q1 | $272K | Buy |
40,405
+19,388
| +92% | +$130K | ﹤0.01% | 1875 |
|
|
2020
Q4 | $96K | Sell |
21,017
-13,661
| -39% | -$62.4K | ﹤0.01% | 2228 |
|
|
2020
Q3 | $135K | Sell |
34,678
-20,595
| -37% | -$79.9K | ﹤0.01% | 2077 |
|
|
2020
Q2 | $263K | Hold |
55,273
| – | – | ﹤0.01% | 1737 |
|
|
2020
Q1 | $192K | Hold |
55,273
| – | – | ﹤0.01% | 1720 |
|
|
2019
Q4 | $266K | Buy |
55,273
+14,736
| +36% | +$71K | ﹤0.01% | 1821 |
|
|
2019
Q3 | $118K | Hold |
40,537
| – | – | ﹤0.01% | 2240 |
|
|
2019
Q2 | $291K | Hold |
40,537
| – | – | ﹤0.01% | 1804 |
|
|
2019
Q1 | $574K | Hold |
40,537
| – | – | 0.01% | 1370 |
|
|
2018
Q4 | $548K | Hold |
40,537
| – | – | 0.01% | 1311 |
|
|
2018
Q3 | $900K | Buy |
+40,537
| New | +$900K | 0.01% | 1184 |
|